You are on page 1of 66

Management of Toxicity

Causes of self-poisoning:

Accidental:

Children less than 5 years by sugar coated tablets.

Inhalation of organophosphorus pesticides.

Overdose.
Causes of self-poisoning:

Deliberate:

Suicidal attempts (in response to depression or specific life events).


Management Principles:

1 Immediate and supportive measures.

2 Absorption prevention.

3 Elimination of toxicant.

4 Specific antidote.
1) Immediate and Supportive measures

Remove patient from contact with poison, for example gases.

Preserve any evidence, for example bottles, thrown tablets,


written notes….

Assess vital signs (Pulse, body temperature, B.P, respiratory rate


& pupil size).

Ensure clear
1) Immediate and Supportive measures

Remove patient from contact with poison, for example gases.

Preserve any evidence, for example bottles, thrown tablets, written notes….

Assess vital signs (Pulse, body temperature, B.P, respiratory rate & pupil size).

Ensure clear

= Airway

= Breathing

= Circulation
1) Immediate and Supportive measures

A=Air way

 Causes of air way obstruction:

Drug-induced mucosal swelling.

Increased salivation.

Posterior displacement of
the tongue.

Swallowing of foreign bodies.


1) Immediate and Supportive measures
A=Air way
 Symptoms of airway obstruction:

Dyspnea.
Tachypnea
Air hunger.
Cyanosis.
Hoarseness(stridor).
Diaphoresis.
Drooling.
.
1) Immediate and Supportive measures
A=Air way
Management of airway obstruction:
Suction of excessive secretions.
Chin lift maneuver.
1) Immediate and Supportive measures
A=Air way
Management of airway obstruction:
Suction of excessive secretions.
Chin lift maneuver.
Nasopharyngeal intubation  Alert patients.
Oropharyngeal intubation  Comatosed patients.
1) Immediate and Supportive measures
A=Air way
Management of airway obstruction:
Suction of excessive secretions.
Chin lift maneuver.
Nasopharyngeal intubation  Alert patients.
Oropharyngeal intubation  Comatose patients.
1) Immediate and Supportive measures
A= Air way

Management of airway obstruction:


Suction of excessive secretions.
Chin lift maneuver.
Nasopharyngeal intubation  Alert patients.
Oropharyngeal intubation  Comatose patients.
1) Immediate and Supportive measures

A=Air way
Management of airway obstruction:
• Suction of excessive secretions.
• Chin lift maneuver.
• Nasopharyngeal intubation  Alert patients.
• Oropharyngeal intubation  Comatose patients.

• Finally  Emergency Cricothyrotomy.


1) Immediate and Supportive measures
B = Breathing

 Causes of respiratory depression:

• Drug-induced respiratory depression (Sedatives & hypnotic


such as barbiturates & BDZs).

• Pulmonary edema & pneumonitis.

• Bronchospasm.
1) Immediate and Supportive measures
B = Breathing

Management of respiratory depression:

Nasotracheal intubation  Alert patients.


Orotracheal intubation  Comatosed patients.
1) Immediate and Supportive measures
C =Circulation

The shock is the clinical picture in which the patient shows signs
of inadequate tissue perfusion.

 Symptoms of shock:

SHOCK

Coma
1) Immediate and Supportive measures
C =Circulation

 Management of shock:
Initially:
• Trendlenburg position.

• Saline Infusion.
1) Immediate and Supportive measures
C =Circulation

 Management of shock:
If the patient doesn't respond to 2L infusion & the signs of shock
persist, the vasopressors should be used:
N.B.
Dopamine 1) Dopamine at low dose  stimulates
dopamine receptors  renal & mesenteric
2-5 µg/kg/minute vasodilatation.
vasopressors up to 20 µg/kg/
minute 2) Dopamine at medium dose  stimulates
cardiac β1 receptors ↑cardiac contractility
& C.O.P.
Norepinephrine 3) Dopamine at high dose  stimulates α1
0.1-0.2 µg/kg/minute. receptors  systemic vasoconstriction.
2) Preventing absorption (Gut Decontamination)
 It is usually not effective if more than 4-6 hrs passed
after poison ingestion.

 It is used only for orally ingested poisons.

 Methods of gut decontamination:


Gastric Activated Whole
Emesis Cathertics Bowel
Lavage Charcoal
Irrigation
2) Preventing absorption (Gut Decontamination)
Emesis
Method:
By the use of syrup of ipeca.
The active ingredients are two alkaloids, emetine
&cephaeline.

Dose:
In children 6-9 months  5 ml ipeca syrup + 120 ml water.
9-12 months  10 ml ipeca + 120 ml water
1- 12 years 15 ml ipeca + 120 ml water.
> 12 year  30 ml ipeca + 250-350 ml water.

The dose can be repeated if emesis has not occurred in 30 minutes.


2) Preventing absorption (Gut Decontamination)
Emesis
Don’t use for emesis
• Water alone: hyponatremia
• Finger down throat: incomplete, dangerous, unsuccessful
• Cu & Zn SO4: not reliable & if absorbed may cause poisoning.
• Apomorphine: may cause lethargy, depress resp. center,
hypotension

Complications:
Prolonged
Lethargy Drowsiness Diarrhea
vomiting
2) Preventing absorption
(Gut Decontamination)
Emesis
Contraindication:
1- Children up to 6 months of age.

2- Comatose patient because of increased risk of aspiration.

3- Seizures (due to compromised gag reflex).

4- Certain toxins:
- Hydrocarbons& volatile substances.
- Corrosives (Caustics).

5- Ingestion of sharp objects.


2) Preventing absorption (Gut Decontamination)

Gastric Lavage
Method:
• performed by introducing warm water alternating
with saline
• use nasogastric (alert patients & children) or an
orogastric (comatose patient) tube into the stomach
• & the removal of stomach contents
by suction.
• For comatosed patients (with absent gag
reflex) or hydrocarbons use cuffed
endotracheal tube to prevent
aspiration.
2) Preventing absorption (Gut Decontamination)
Gastric Lavage
Precautions:
Warm solution should be used.
To avoid hypothermic shock
Warm water alternating with saline
To avoid hyponatremia
The patient should be placed on his left side.
liver blocks the junction between stomach & small intestine, and therefore
the toxin is kept in the stomach available for lavage.

G.L can be used in comatosed patients with concurrent insertion


of cuffed endotracheal intubation.
2) Preventing absorption (Gut Decontamination)
Gastric Lavage
Complications:

Esophageal Epistaxis Empyema


perforation
2) Preventing absorption (Gut Decontamination)
Gastric Lavage
Contraindications:

Varicoses.

Gastric ulcers.

Corrosives (Caustics) intoxication.

Ingestion of sharp objects.

Cardiac dysrhythmias (must be controlled before initiating G.L


because insertion of the tube may create a vagal response
leading to life-threatening dysrhythmia or cardiac arrest.
2) Preventing absorption (Gut Decontamination)
Gastric Lavage
Other washing solutions for specific toxins:
Poison Solution
Formaldehyde Ammonium Acetate
Oxalic acid, fluoride Ca gluconate
Silver nitrate Normal saline
Alkaloids, mushroom K permenganate
Ferrous sulfate NaHCO3
Alkaloids Tannic acid
Iodine Starch solution
• Formaldehyde + ammonia Hexa/penta-methylene
tetramine (inert)

• Ferrous iron + NaHCO3 FeCO3 (poorly absorbed)

• alkaloids + K permanganate OR tannic acid ppt

• Iodine + starch blue colour as indicator

• HF + Ca gluconate ppt
2) Preventing absorption (Gut Decontamination)
Activated Charcoal

Method:
Activated charcoal effectively adsorbs a variety of drugs &
chemicals.

Dose:
1-2 g/kg or 50 gm (10 table spoonful)

It is mixed with 70% sorbitol to avoid constipation & resorption.


2) Preventing absorption (Gut Decontamination)
Activated Charcoal

Complications:

Constipation. Intestinal Aspiration


obstruction. pneumonitis
2) Preventing absorption (Gut Decontamination)
Activated Charcoal
Contraindications:
In comatosed patient unless the cuffed intubation is used.
Activated charcoal doesn't bind well to:

Boric acid.
Pesticides.
Ferrous salts (as ferrous sulphate).
Cyanide.
Caustics.
Alcohols.
Petroleum distillates.
2) Preventing absorption (Gut Decontamination)
Cathertics
(Purgation)

Saline/salt Saccharide Oil based


Magnesium Citrate
Sodium Phosphate Sorbitol Not used now
because of
N.B. although safe, increased risk of
but not given to lipoid pneumonia
children < 1 y, &
with caution in 3 y
age
2) Preventing absorption (Gut Decontamination)
Cathertics
Complications:

Abdominal Prolonged Electrolyte


distention & diarrhea. disturbances
cramps. (when given by
the gastric lavage
technique).
2) Preventing absorption (Gut Decontamination)
Cathertics
Contraindications:
• Magnesium cathartics should be avoided in patients with renal
failure &/or C.N.S problems. WHY??
(Renal failure  ↓ Magnesium excretion  Magnesium accumulation
Electrolyte disturbance and C.N.S depression)
• Sodium salts should be avoided in patients with renal failure,
heart failure, &/or hypertension.

• Absence of bowel sounds.


• Intestinal obstruction
• Pre-existing electrolyte disturbance,
• GI bleeding, perforation, peritonitis.
• Poisoning with corrosives
• Severe diarrhea
2) Preventing absorption (Gut Decontamination)
Whole Bowel Irrigation
(WBI)

It is the complete irrigation of the bowel by PEG (Colyte®).

The patient receives PEG until clear effluent is attained.


3) Elimination Enhancement

Non
Extracorporeal
Extracorporeal
system
system
Hemodialysis

Hemoperfusion Peritoneal Dialysis

Exchange Transfusion Forced Diuresis


3) Elimination Enhancement
Hemodialysis
Requirements:

When large amounts of drug are retained in plasma.

The drug molecular weight should be less than 500 Dalton so can
pass easily across the dialysis membrane.

The drug should be water soluble.

The drug should be of low protein binding.

Heparin should be administrated before dialysis to avoid blood


coagulation.
3) Elimination Enhancement
Hemodialysis
3) Elimination Enhancement
Hemodialysis
Indications:

Severely intoxicated patients who don't respond to early


supportive management.

Renal failure (where forced diuresis can't be applied).

Prolonged coma.

If lethal amounts of drug was absorbed despite gut


decontamination.

Presence of significant quantity of a toxin that is metabolized to a


toxic metabolite.
3) Elimination Enhancement
Hemodialysis
Complications:
Hypotension.

Electrolyte disturbance.

Bleeding.

Air embolism.

Thrombocytopenia.

Infection.
3) Elimination Enhancement
Hemodialysis
Contraindications:

Presence of antidote.

Patient receiving anticoagulants (heparin).

Coagulopathy or bleeding ulcer.


3) Elimination Enhancement
Hemoperfusion

 It is a method for removing toxic material by pumping blood


through a cartridge of adsorbent material such as activated
charcoal or resin.
Advantages:
Hemoperfusion can be used with:
-Drugs of high molecular weight.

-Protein bound drug (Phenytoin).

- Poorly water soluble drugs.


- N.B. Heparin is used here.
3) Elimination Enhancement
Hemoperfusion

Contraindication & Complications

???
3) Elimination Enhancement
Exchange transfusion

It is infrequently used.

It is the removal of the patient's blood & replacement with


fresh whole blood.
3) Elimination Enhancement
Exchange transfusion

Indications:

Iron toxicity.

Chloramphenicol toxicity.

Patients who are refractory to other enhanced elimination


methods or antidotes.
3) Elimination Enhancement
Exchange transfusion

Complications:

Mismatches.

Chills.

Hypotension.

Infection.

Bleeding.
3) Elimination Enhancement
Peritoneal Dialysis

 The toxins diffuse from mesenteric capillaries across the


peritoneal membrane into a washing solution in the peritoneal
cavity.
3) Elimination Enhancement
Peritoneal Dialysis

 The toxins diffuse from mesenteric capillaries across the


peritoneal membrane into a washing solution in the peritoneal
cavity.

Advantages:

It is well tolerated.

It doesn’t require heparinization.


3) Elimination Enhancement
Peritoneal Dialysis

Indications:

when hemodialysis or hemoperfusion is unavailable or


contraindicated, such as patients with bleeding disorders or
receiving anticoagulant therapy.

Can be used in patients with acute renal failure.


3) Elimination Enhancement
Peritoneal Dialysis

Complications:

Pain.

Peritonitis.

Electrolyte disturbance.

Infection.
3) Elimination Enhancement
Forced Diuresis
Principle:
Many drugs are weak acids or weak bases.

At physiological pH, most drugs are partially ionized (polar).

It is known that the ionized form is increased when the drug is placed in a
medium opposite to its nature (i.e. the acidic drug is significantly ionized in
alkaline medium & the basic drug is ionized in acidic medium).

The ionized form is unable to cross through cell membranes.

The goal of forced diuresis is to enhance renal excretion by increasing the


amount of the ionized form in the urine  the drug is trapped in renal
tubules & not reabsorbed Increased excretion
3) Elimination Enhancement
Forced Diuresis

Requirements:

Low protein binding.

Limited metabolism & tissue distribution.

High renal clearance (normal kidney functions).


3) Elimination Enhancement
Forced Diuresis

Forced Alkaline Diuresis Forced acidic Diuresis

Used for acidic toxins such as Used for basic drugs, but its use is now
salicylates, phenobarbital. limited because the adverse effects are
common and the process is technically
The urine is alkalinized by I.V infusion of difficult.
sodium bicarbonate.
The method is carried out using
Complications  pulmonary or cerebral ammonium chloride (oral or I.V).
edema – electrolyte disturabances.
Complications  ammonia
encephalopathy.
4) Antidotes
1) Competitive Antidote

 When the antidote competes with the toxin at its


site of action (same receptor).
 Examples:

• Atropine acts at muscarinic receptors to block the toxic effects


of Acetylcholine.

• Naloxone acts at opioid receptors to reverse the effects of


narcotic analgesic.

• Flumazenil competes with BZDs at its binding site near the


GABA receptors.
4) Antidotes
2) Non-Competitive Antidote

 When the antidote reverses the effect of the toxin


at a different site
 Example:

• Organophosphorous pesticides act by inhibiting the


enzyme “acetylcholinestrase”.

• Atropine acts to dampen the binding of excessive


acetylcholine to muscarinic recetors.
4) Antidotes
3) Chelating Antidote

 When the antidote forms a non toxic water soluble


complex with the toxin, to be excreted out of the
body
 Example:
BAL: for most metals such as gold, lead, mercury & arsenic.

EDTA: for lead.

Penicillamine: for lead & copper.

Deferrioxamine: for iron.

Dicobalt EDTA: for cyanide.


4) Antidotes
4) Antidote affecting toxin metabolism

 When the antidote acts at a particular site in the metabolic


pathway of the toxin to prevent its toxicity &/or accelerates
its metabolism to a non toxic metabolite.
 Example:
Alcohol dehydrogenase
Methanol Formaldehyde + Formic acid
(Toxin) Cause optic nerve toxicity (Blindness)
4) Antidotes
4) Antidote affecting toxin metabolism

 When the antidote act at particular site in the metabolic


pathway of the toxin to prevent its toxicity &/or accelerate
its metabolism to a non toxic metabolite.
 Example:
Alcohol dehydrogenase
Methanol Formaldehyde + Formic acid
(Toxin) Cause optic nerve toxicity (Blindness)

Ethanol Acetaldehyde + acetic a’


(Antidote)
Non Toxic Metabolite
4) Antidotes
4) Antidote affecting toxin metabolism
 When the antidote act at particular site in the metabolic
pathway of the toxin to prevent its toxicity &/or accelerate
its metabolism to a non toxic metabolite.
 Example:
Toxicity

Cyanide Sodium Thiosulphate


(Antidote)
+ Nitrites cyanoMetHb ++++++++++++++++++++++

Sodium Thiocyanate
(More water soluble
& less toxic).
4) Antidotes
4) Antidote affecting toxin metabolism

 When the antidote act at particular site in the metabolic


pathway of the toxin to prevent its toxicity &/or accelerate
its metabolism to a non toxic metabolite.
 Example:

N-Acetylcysteine: provides substrate for conjugation of


the toxic metabolite (NAPQI) of paracetamol.
4) Antidotes
5) Antibody Antidote

 When the antidote neutralizes the toxin by binding to it.


 Example:

Specific antibody fragment (Fab) for digoxin:

It is prepared by injecting sheep or horse with the toxic substance


 formation of antibodies for the toxicant  Ag-Ab Complex 
fractionation to remove the antigenic fragment & retain the
specific Antigen Binding Fragment (Fab).
4) Antidotes
6) Antibody affecting enzyme-poison complex

 Example:

Oximes (ex: pralidoxime, PAM):


it is used in the treatment of
OPCs toxicity. It acts by
reactivating acetylcholine
esterase.

You might also like